ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.70
0.13%
Dow Jones
38,884.26
0.08%
US Dollar vs MXN
16.92865
0.13%
Brent Oil
82.535
-0.40%
Bitcoin
62,657.79
0.52%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Gsk Plc (GSK)

  7. Gsk Plc (GSK) Noticias

GSK

Gsk (GSK)

Gsk Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:GSK
FechaHoraFuenteTítuloSímboloCompañía
03/05/202409:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
01/05/202409:00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
01/05/202402:50Alliance NewsAlliance NewsTOP NEWS: GSK expects momentum to continue after strong first quarterLSE:GSKGsk Plc
01/05/202401:00RNS Regulatory NewsGSK PLC 1st Quarter ResultsLSE:GSKGsk Plc
24/04/202403:14Alliance NewsAlliance NewsGSK's Jemperli with chemotherapy accepted for priority review by FDALSE:GSKGsk Plc
24/04/202401:00RNS Regulatory NewsGSK PLC US FDA accepts new indication filing for JemperliLSE:GSKGsk Plc
17/04/202402:46Alliance NewsAlliance NewsTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatmentLSE:GSKGsk Plc
17/04/202401:05RNS Regulatory NewsGSK PLC GSK announces additional EAGLE-1 resultsLSE:GSKGsk Plc
17/04/202401:00RNS Regulatory NewsGSK PLC Results from long-term data relating to ShingrixLSE:GSKGsk Plc
16/04/202408:11RNS Regulatory NewsGSK PLC Amendment - Director/PDMR ShareholdingLSE:GSKGsk Plc
16/04/202402:59Alliance NewsAlliance NewsGSK's latest meningitis vaccine accepted for review by US regulatorLSE:GSKGsk Plc
16/04/202401:00RNS Regulatory NewsGSK PLC FDA accepts GSK meningitis vaccine candidate fileLSE:GSKGsk Plc
08/04/202404:27Alliance NewsAlliance NewsIN THE KNOW: Barclays ups GSK price target but HIV drug nerves remainLSE:GSKGsk Plc
04/04/202406:05RNS Regulatory NewsGSK PLC Replacement - Total Voting RightsLSE:GSKGsk Plc
25/03/202408:00RNS Regulatory NewsGSK PLC Notice of AGMLSE:GSKGsk Plc
22/03/202411:20RNS Regulatory NewsGSK PLC Transfer of Treasury SharesLSE:GSKGsk Plc
18/03/202404:30RNS Regulatory NewsGSK PLC New Phase III Jemperli data in endometrial cancerLSE:GSKGsk Plc
18/03/202403:47Alliance NewsAlliance NewsGSK says Jemperli combination gets good results for endometrial cancerLSE:GSKGsk Plc
08/03/202411:12RNS Regulatory NewsGSK PLC Board Committee ChangeLSE:GSKGsk Plc
07/03/202403:38Alliance NewsAlliance NewsGSK observes positive data in Blenrep trial for blood cancer treatmentLSE:GSKGsk Plc
07/03/202401:00RNS Regulatory NewsGSK PLC GSK announces positive Blenrep DREAMM-8 resultsLSE:GSKGsk Plc
06/03/202410:00RNS Regulatory NewsGSK PLC ViiV LAI vs oral SOC data in adherence-challengedLSE:GSKGsk Plc
05/03/202411:24RNS Regulatory NewsGSK PLC GSK Annual Report 2023 on Form 20-FLSE:GSKGsk Plc
05/03/202405:03Alliance NewsAlliance NewsGSK says ViiV's cabotegravir study supports longer HIV dose intervalLSE:GSKGsk Plc
05/03/202401:00RNS Regulatory NewsGSK PLC New ViiV LA formulation potential 4-month dosingLSE:GSKGsk Plc
01/03/202406:15RNS Regulatory NewsGSK PLC GSK publishes Annual Report 2023LSE:GSKGsk Plc
29/02/202403:44Alliance NewsAlliance NewsTOP NEWS: GSK avoids "protracted litigation" with Zantac settlementLSE:GSKGsk Plc
29/02/202401:05RNS Regulatory NewsGSK PLC Directorate ChangeLSE:GSKGsk Plc
29/02/202401:00RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
26/02/202402:25Alliance NewsAlliance NewsGSK gonorrhoea treatment achieves efficacy endpoint in latest trialLSE:GSKGsk Plc
 Showing the most relevant articles for your search:LSE:GSK

Su Consulta Reciente

NASDAQ
AAPL
Apple
FX
EURUSD
Euro vs US Dollar
CCOM
OILBRENT
Brent Oil
CCOM
SILVER
SILVER
NASDAQ
MSFT
Microsoft
NASDAQ
NVDA
NVIDIA
AMEX
XLE
Energy Select Sector SPDR
COIN
BTCUSD
Bitcoin
NYSE
JPM
JP Morgan Chase
USOTC
RHHBY
Roche (QX)
NYSE
NKE
Nike
AMEX
SPY
SPDR S&P 500
AMEX
XLV
Health Care Select Sector
NYSE
BAC
Bank of America
NYSE
AXP
American Express
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados